Skip Navigation LinksHome > Current Issue > Contributor Index

April 2015 - Volume 26 - Issue 4 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 7 Next
Author Name Article
Ai, Guanhua

A combination of 2D similarity search, pharmacophore, and molecular docking techniques for the identification of vascular endothelial growth factor receptor-2 inhibitors

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Annede, Pierre

Safety of spinal radiotherapy in metastatic cancer patients receiving bevacizumab therapy: a bi-institutional case series

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Artibani, Walter

Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ascierto, Paolo A.

Vemurafenib beyond progression in a patient with metastatic melanoma: a case report

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bauduceau, Olivier

Safety of spinal radiotherapy in metastatic cancer patients receiving bevacizumab therapy: a bi-institutional case series

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bimbatti, Davide

Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Boeck, Stefan

Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bosacki, Claire

Safety of spinal radiotherapy in metastatic cancer patients receiving bevacizumab therapy: a bi-institutional case series

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brunelli, Matteo

Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bruns, Christiane J.

Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cai, Xu-Wei

Full-dose pemetrexed plus cisplatin combined with concurrent thoracic radiotherapy for previously untreated advanced nonsquamous non-small cell lung cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Camaj, Peter

Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Caracò, Corrado

Vemurafenib beyond progression in a patient with metastatic melanoma: a case report

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ceccaldi, Bernard

Safety of spinal radiotherapy in metastatic cancer patients receiving bevacizumab therapy: a bi-institutional case series

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chang, Tsuey-Yu

Antiangiogenesis as the novel mechanism for justicidin A in the anticancer effect on human bladder cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chargari, Cyrus

Safety of spinal radiotherapy in metastatic cancer patients receiving bevacizumab therapy: a bi-institutional case series

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Haiyan

A combination of 2D similarity search, pharmacophore, and molecular docking techniques for the identification of vascular endothelial growth factor receptor-2 inhibitors

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Qiuxiang

The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Wenqing

Inhibition of NADPH oxidase protects against metastasis of human lung cancer by decreasing microRNA-21

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Yanbin

Combination of SF1126 and gefitinib induces apoptosis of triple-negative breast cancer cells through the PI3K/AKT–mTOR pathway

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 7 Next